Meta-analysis of three genome-wide association studies identifies two loci that predict survival and treatment outcome in breast cancer

The majority of breast cancers are driven by the female hormone oestrogen via oestrogen receptor (ER) alpha. ER-positive patients are commonly treated with adjuvant endocrine therapy, however, resistance is a common occurrence and aside from ER-status, no unequivocal predictive biomarkers are curren...

Descripción completa

Detalles Bibliográficos
Autores principales: Khan, Sofia, Fagerholm, Rainer, Kadalayil, Latha, Tapper, William, Aittomäki, Kristiina, Liu, Jianjun, Blomqvist, Carl, Eccles, Diana, Nevanlinna, Heli
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2017
Materias:
Meta-Analysis
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5790536/
https://www.ncbi.nlm.nih.gov/pubmed/29423119
http://dx.doi.org/10.18632/oncotarget.22747

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5790536/
https://www.ncbi.nlm.nih.gov/pubmed/29423119
http://dx.doi.org/10.18632/oncotarget.22747

Ejemplares similares